Related by context. Frequent words. (Click for all words.) 67 prospective randomized controlled 64 epithelial ovarian cancer 64 multicenter randomized 64 nab paclitaxel 64 blind randomized controlled 63 double blinded placebo 63 prospective multicenter 63 Phase III randomized 63 substudy 63 Multicenter 63 placebo controlled clinical 63 placebo controlled Phase 62 randomized placebo controlled 62 chemoradiotherapy 62 randomized 62 randomized clinical 61 placebo controlled randomized 61 multicenter randomized double 61 irbesartan 61 neoadjuvant 61 liver transplant recipients 61 carotid artery stenting 61 Thrombolysis 61 PCa 61 multicentre 61 PRECISE 60 bleomycin 60 prospective observational 60 immunohistochemical 60 active comparator 60 pharmacodynamic effects 60 metastatic renal cell carcinoma 60 prospective randomized 60 mycophenolate mofetil 60 HER2 positive metastatic breast 60 superficial bladder cancer 60 statistically significant p = 60 Estradiol 60 decitabine 59 subgroup analyzes 59 blind randomized 59 neoadjuvant chemotherapy 59 randomized controlled 59 breast carcinoma 59 PRECiSE 59 PREZISTA r 59 PegIntron 59 retrospective cohort study 59 NLX P# 59 randomized controlled clinical 59 μg kg 59 adalimumab 59 goserelin 59 RRMS patients 59 EBRT 59 Randomized 59 noninferiority 59 multivariate analyzes 59 XELOX 58 chlorambucil 58 cystectomy 58 randomized Phase III 58 HSCT 58 ascending doses 58 teriparatide 58 dose regimens 58 biochemical recurrence 58 multicenter 58 randomized controlled trial 58 blind randomized placebo 58 nephrectomy 58 pheochromocytoma 58 dose cohorts 58 serum concentrations 58 randomized #:# 58 multicenter clinical 58 mg kg dose 58 QTc 58 plus dexamethasone 58 relapsed refractory multiple myeloma 58 Phase Ib clinical 58 placebo controlled 58 TACE 58 glatiramer acetate 58 mRCC 57 metastatic hormone refractory 57 ANOVA 57 MIRCERA 57 prospective cohort 57 Natalizumab 57 FDG PET 57 intravesical 57 label dose escalation 57 RADIANT 57 placebo controlled studies 57 vertebral fracture 57 label multicenter 57 dose escalation trial 57 neoadjuvant therapy 57 malignant pleural mesothelioma 57 ischemic cardiomyopathy